What is the recommended aspirin dosage for treating rheumatic fever in children (mg/kg per day) and adults (maximum daily dose)?

Aspirin Dosing in Rheumatic Fever

For acute rheumatic fever with arthritis or carditis, administer aspirin at 80–100 mg/kg/day divided into 4 doses during the acute phase, then reduce to low-dose aspirin (3–5 mg/kg/day) once fever resolves, continuing until 6–8 weeks after disease onset if no coronary abnormalities are present. 1

Acute Phase Dosing

Children

• High-dose aspirin: 80–100 mg/kg/day divided into 4 doses during the acute inflammatory phase 2, 1
• This high dose provides anti-inflammatory effects and should be administered concurrently with IVIG 1
• Duration of high-dose therapy varies by institution:
  • Some centers reduce the dose 48–72 hours after defervescence 2, 1
  • Others continue until day 14 of illness AND 48–72 hours after fever cessation 1

Adults

• While specific adult dosing for rheumatic fever is not explicitly stated in guidelines, extrapolation from pediatric weight-based dosing would suggest similar mg/kg dosing
• Maximum daily doses for adults typically do not exceed 4–6 grams per day for anti-inflammatory purposes (based on general medical knowledge)

Maintenance Phase Dosing

Low-Dose Aspirin

• 3–5 mg/kg/day as a single daily dose (maximum 81 mg/day in children) 3, 1
• This provides antiplatelet effects rather than anti-inflammatory effects
• Continue until 6–8 weeks after disease onset if no coronary abnormalities are documented 1
• If coronary abnormalities develop, aspirin may be continued indefinitely 1

Timing of Dose Reduction

The transition from high-dose to low-dose aspirin should occur when:

• Patient has been afebrile for 48–72 hours 2, 1, OR
• Day 14 of illness has been reached AND patient has been afebrile for 48–72 hours 1

Critical Safety Considerations

Reye Syndrome Risk

• Aspirin poses a risk of Reye syndrome in children with active influenza or varicella infection 4
• Children on long-term aspirin therapy should receive annual influenza vaccination 1, 4
• Parents must be instructed to contact their physician immediately if the child develops symptoms of or is exposed to influenza or varicella 1
• Consider temporarily substituting another antiplatelet medication during the 6-week period after varicella vaccination 1

Hepatotoxicity Monitoring

• Aspirin-induced hepatotoxicity occurs in approximately 17% of children with acute rheumatic fever 5
• Hepatotoxicity is more common in children under 11 years of age (69% of cases) 6
• Monitor liver enzymes regularly during treatment 5
• If hepatotoxicity develops, naproxen or ibuprofen can be safely substituted 6, 5

Drug Interactions

• Avoid concurrent ibuprofen in patients taking aspirin for antiplatelet effects, as ibuprofen antagonizes aspirin's irreversible platelet inhibition 1
• This is particularly important in patients with coronary aneurysms requiring antiplatelet therapy 1

Alternative Anti-Inflammatory Agents

Recent evidence suggests ibuprofen may be a safer alternative, particularly in young children:

• A 2022 study found no difference in clinical efficacy between ibuprofen and aspirin for ARF with isolated arthritis and mild carditis 6
• Ibuprofen caused significantly fewer liver enzyme elevations (18% vs 62%, p=0.009) 6
• No clinical side effects were observed with ibuprofen compared to three patients with side effects in the aspirin group 6
• A 2021 study confirmed that naproxen or ibuprofen can be used safely when aspirin hepatotoxicity develops 5

Clinical Pearls

• The high-dose aspirin regimen (80–100 mg/kg/day) may require doses exceeding 100 mg/kg/day in some children to achieve therapeutic salicylate levels >20 mg/dL 7
• Symptomatic liver enzyme elevations are common in the first 3 months of therapy but generally return to normal despite continuation of treatment 7
• The 2020 Australian guideline emphasizes close monitoring for aspirin toxicity and consideration of alternative NSAIDs in high-risk populations 8
• Despite decades of use, a 2015 Cochrane review found little evidence of benefit for corticosteroids or anti-inflammatory agents in reducing long-term valve damage, though this should not deter symptomatic treatment of acute inflammation 9